Evidence map›Paper›PMID 24347429›Full record

ReviewJournal of labelled compounds & radiopharmaceuticals2014

The inverse electron demand Diels-Alder click reaction in radiochemistry.

Thomas Reiner, Brian M Zeglis

Open access · greenAbstract readReview
In one paragraph

Review in Journal of labelled compounds & radiopharmaceuticals, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 61 citations in OpenAlex.

  1. Article
  2. A novelEJNMMI radiopharmacy and chemistry · 2026
    Article
  3. Article
  4. Review
  5. Toward OptimizedPharmaceutics · 2022
    Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. A Cleavable CJournal of the American Chemical Society · 2020
    Article
  12. Article
  13. Article
  14. Site-SpecificPharmaceutics · 2019
    Article
  15. A Dual-Modality Linker Enables Site-Specific Conjugation of Antibody Fragments forJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2019
    Article
  16. ACS omega · 2019
    Article
  17. HydrophilicChemical communications (Cambridge, England) · 2019
    Article
  18. Leveraging Bioorthogonal Click Chemistry to ImproveClinical cancer research : an official journal of the American Association for Cancer Research · 2019
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Thomas ReinerDepartment of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Brian M Zeglis
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
PET Imaging of Topoisomerase-II Expression in Breast CancerF32CA144138 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ZEGLIS, BRIAN MATTHEW · 2009 to 2011
$144k
NCI NIH HHS F32 CA144138NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

The inverse electron-demand Diels-Alder (IEDDA) cycloaddition between 1,2,4,5-tetrazines and strained alkene dienophiles is an emergent variety of catalyst-free 'click' chemistry that has the potential to have a transformational impact on the synthesis and development of radiopharmaceuticals. The ligation is selective, rapid, high-yielding, clean, and bioorthogonal and, since its advent in 2008, has been employed in a wide variety of chemical settings. In radiochemistry, the reaction has proven particularly useful with (18)  F and has already been utilized to create a number of (18)  F-labeled agents, including the PARP1-targeting small molecule (18)  F-AZD2281, the αv β3 integrin-targeting peptide (18)  F-RGD, and the GLP-1-targeting peptide (18)  F-exendin. The inherent flexibility of the ligation has also been applied to the construction of radiometal-based probes, specifically the development of a modular strategy for the synthesis of radioimmunoconjugates that effectively eliminates variability in the construction of these agents. Further, the exceptional speed and biorthogonality of the reaction have made it especially promising in the realm of in vivo pretargeted imaging and therapy, and pretargeted imaging strategies based on the isotopes (111) In, (18)  F, and (64) Cu have already proven capable of producing images with high tumor contrast and low levels of uptake in background, nontarget organs. Ultimately, the characteristics of inverse electron-demand Diels-Alder click chemistry make it almost uniquely well-suited for radiochemistry, and although the field is young, this ligation has the potential to make a tremendous impact on the synthesis, development, and study of novel radiopharmaceuticals.

Indexed as

ElectronsAnimalsCycloaddition ReactionHumansRadiochemistryRadiopharmaceuticalsRadiopharmaceuticalsclick chemistryDiels-Aldernorbornenepretargetingradiochemistrytetrazinetranscyclooctene

Identifiers

PMID24347429
PMCPMC4048816
OpenAlexW2152209682

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.